Evaluation of a near-infrared version of TMR-PEG1k, a high-performance untargeted contrast agent for fluorescence-guided surgery, using fluorescence cryotomography
Cy7-PEG1k did not retain the favorable properties exhibited by TMR-PEG1k and thus is not a suitable NIR analog for this agent.
Authors
- Augustino V. Scorzo (ORCID: https://orcid.org/0000-0001-5573-5985)
- David W. Roberts (ORCID: https://orcid.org/0000-0002-8677-3930)
- Keith D. Paulsen (ORCID: https://orcid.org/0000-0002-6692-3196)
- Scott C. Davis
- Rendall R. Strawbridge
- Caleb Y. Kwon
Institutions
- Dartmouth College (US)
- Dartmouth–Hitchcock Medical Center (US)
Publication Details
- Journal
- Journal of Biomedical Optics
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1117/1.jbo.30.12.126004
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Oregon Health and Science University